Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
Status:
Terminated
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Phase 3, placebo controlled, double-blind, randomized clinical study to determine safety,
tolerability, and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in
symptomatic subjects with pulmonary arterial hypertension (PAH). Part 1 and Part 2